Antibodies against two G-protein coupled receptors (GPCRs), angiotensin II type 1 receptor
(AT1R) and endothelin A receptor (ETAR) are among a growing number of autoantibodies …

Although solid organ transplant results have improved significantly in recent decades, a
pivotal cause of impaired long-term outcome is the development of antibody-mediated …

Introduction Chronic active antibody‐mediated rejection (cAMR) is a major determinant of
late allograft failure. Rituximab/immunoglobulins (IVIg)+ plasma exchange (PLEX) showed …

Retrospective studies of angiotensin II type 1 receptor antibodies (AT1R-Ab) and anti-
endothelial cell antibodies (AECA) have linked these antibodies to allograft injury. Because …

The Banff antibody‐mediated rejection (ABMR) classification is vulnerable to
misinterpretation, but the reasons are unclear. To better understand this vulnerability, we …

To date, human leukocyte antigens (HLA) have been the major focus in the approach to
acute and chronic antibody-mediated rejection (AMBR) in solid-organ transplantation …

The transcriptional regulation of B-cell response to antigen stimulation is complex and
involves an intricate network of dynamic signals from cytokines and transcription factors …

Immunological injury to the allograft, specifically by antibodies to de novo donor specific
human leukocyte antigen (dn DSA) and antibody mediated injury and rejection are the major …

Anti-endothelial cell antibodies (AECAs) have been correlated with increased acute and
chronic rejection across all organ types and early graft dysfunction in kidney and heart …

Background. Antibody-mediated rejection (AMR) following orthotopic heart transplant (OHT)
causes significant morbidity and mortality. There are limited data on antibodies to the …